Compile Data Set for Download or QSAR
Report error Found 347 Enz. Inhib. hit(s) with all data for entry = 10904
LigandPNGBDBM577094(US11472805, Example 11 | (7S)-10-(4-Chlorophenyl)-...)
Affinity DataIC50: 0.300nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577172(US11472805, Example 76 | 10-(4-Chloro-3-fluorophen...)
Affinity DataIC50: 0.310nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577135(US11472805, Example 40 | 8-Cyclopropyl-10-(3,4,5-t...)
Affinity DataIC50: 0.410nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577077(US11472805, Example 2 | 10-(4-Chlorophenyl)-8-cycl...)
Affinity DataIC50: 0.420nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577126(US11472805, Example 32 | 10-(4-Chloro-3-fluorophen...)
Affinity DataIC50: 0.450nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577094(US11472805, Example 11 | (7S)-10-(4-Chlorophenyl)-...)
Affinity DataIC50: 0.520nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577172(US11472805, Example 76 | 10-(4-Chloro-3-fluorophen...)
Affinity DataIC50: 0.550nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577094(US11472805, Example 11 | (7S)-10-(4-Chlorophenyl)-...)
Affinity DataIC50: 0.570nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577128(US11472805, Example 34 | 2-Chloro-5-(8-cyclopropyl...)
Affinity DataIC50: 0.640nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577130(US11472805, Example 36 | 10-(3-Chloro-4-fluorophen...)
Affinity DataIC50: 0.670nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577135(US11472805, Example 40 | 8-Cyclopropyl-10-(3,4,5-t...)
Affinity DataIC50: 0.670nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577126(US11472805, Example 32 | 10-(4-Chloro-3-fluorophen...)
Affinity DataIC50: 0.700nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577143(US11472805, Example 48 | 10-(3-Chlorophenyl)-8-cyc...)
Affinity DataIC50: 0.720nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577079(US11472805, Example 4 | 4-(8-Cyclopropyl-9-oxo-6,7...)
Affinity DataIC50: 0.810nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577173(US11472805, Example 77 | 10-(4-Chloro-2,5-difluoro...)
Affinity DataIC50: 0.840nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577128(US11472805, Example 34 | 2-Chloro-5-(8-cyclopropyl...)
Affinity DataIC50: 0.980nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577077(US11472805, Example 2 | 10-(4-Chlorophenyl)-8-cycl...)
Affinity DataIC50: 0.990nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577102(US11472805, Example 17 | 10-(4-Chlorophenyl)-8-pro...)
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577123(US11472805, Example 29 | 10-(4-Chloro-5-fluoro-2-m...)
Affinity DataIC50: 1nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577123(US11472805, Example 29 | 10-(4-Chloro-5-fluoro-2-m...)
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577143(US11472805, Example 48 | 10-(3-Chlorophenyl)-8-cyc...)
Affinity DataIC50: 1nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577173(US11472805, Example 77 | 10-(4-Chloro-2,5-difluoro...)
Affinity DataIC50: 1nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577130(US11472805, Example 36 | 10-(3-Chloro-4-fluorophen...)
Affinity DataIC50: 1.10nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577142(US11472805, Example 47 | 10-(4-Chloro-2-fluorophen...)
Affinity DataIC50: 1.14nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577091(US11472805, Example 8 | 10-(4-Chloro-3-fluoropheny...)
Affinity DataIC50: 1.19nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577136(US11472805, Example 41 | 8-Cyclopropyl-10-(3-fluor...)
Affinity DataIC50: 1.26nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577171(US11472805, Example 75 | 10-(4-Chlorophenyl)-8-cyc...)
Affinity DataIC50: 1.26nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577091(US11472805, Example 8 | 10-(4-Chloro-3-fluoropheny...)
Affinity DataIC50: 1.27nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577078(US11472805, Example 3 | (6aR)-12-(4-Chlorophenyl)-...)
Affinity DataIC50: 1.38nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577126(US11472805, Example 32 | 10-(4-Chloro-3-fluorophen...)
Affinity DataIC50: 1.44nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577101(US11472805, Example 16 | 4-(8-Cyclopropyl-9-oxo-3,...)
Affinity DataIC50: 1.57nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577140(US11472805, Example 45 | 8-Cyclopropyl-10-(3-fluor...)
Affinity DataIC50: 1.59nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577101(US11472805, Example 16 | 4-(8-Cyclopropyl-9-oxo-3,...)
Affinity DataIC50: 1.78nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577096(US11472805, Example 13 | 8-Cyclopropyl-10-(4-methy...)
Affinity DataIC50: 1.86nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577142(US11472805, Example 47 | 10-(4-Chloro-2-fluorophen...)
Affinity DataIC50: 2nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577172(US11472805, Example 76 | 10-(4-Chloro-3-fluorophen...)
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577129(US11472805, Example 35 | 8-Cyclopropyl-10-(2,3-dih...)
Affinity DataIC50: 2.08nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577122(US11472805, Example 28 | 4-(7-Cyclopropyl-8-oxo-5,...)
Affinity DataIC50: 2.14nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577121(US11472805, Example 27 | 9-(4-Chlorophenyl)-7-cycl...)
Affinity DataIC50: 2.28nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577141(US11472805, Example 46 | 8-Cyclopropyl-10-(2,5-dif...)
Affinity DataIC50: 2.29nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577136(US11472805, Example 41 | 8-Cyclopropyl-10-(3-fluor...)
Affinity DataIC50: 2.38nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577125(US11472805, Example 31 | 10-(4-Chlorophenyl)-8-eth...)
Affinity DataIC50: 2.43nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577123(US11472805, Example 29 | 10-(4-Chloro-5-fluoro-2-m...)
Affinity DataIC50: 2.45nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577107(US11472805, Example 20 | 8-Cyclopropyl-10-(4-methy...)
Affinity DataIC50: 2.52nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577131(US11472805, Example 37 | 8-Cyclopropyl-10-(4-fluor...)
Affinity DataIC50: 2.52nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577182(US11472805, Example 86 | 10-Cyclopentyl-8-cyclopro...)
Affinity DataIC50: 2.52nMAssay Description:The PDE4A3, PDE4B1, PDE4C1 and PDE4D3 assays use the Scintillation Proximity Assay (SPA) technology to measure the inhibition of human recombinant PD...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577090(US11472805, Example 7 | 10-(4-Chloro-3-fluoropheny...)
Affinity DataIC50: 2.53nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577182(US11472805, Example 86 | 10-Cyclopentyl-8-cyclopro...)
Affinity DataIC50: 2.63nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577166(US11472805, Example 70 | 4-(8-Cyclopropyl-9-oxo-8,...)
Affinity DataIC50: 2.67nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577096(US11472805, Example 13 | 8-Cyclopropyl-10-(4-methy...)
Affinity DataIC50: 2.70nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

Displayed 1 to 50 (of 347 total ) | Next | Last >>
Jump to: